DE50106546D1 - Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz - Google Patents

Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz

Info

Publication number
DE50106546D1
DE50106546D1 DE50106546T DE50106546T DE50106546D1 DE 50106546 D1 DE50106546 D1 DE 50106546D1 DE 50106546 T DE50106546 T DE 50106546T DE 50106546 T DE50106546 T DE 50106546T DE 50106546 D1 DE50106546 D1 DE 50106546D1
Authority
DE
Germany
Prior art keywords
preparation
treatment
incontinence
cimicifuga racemosa
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50106546T
Other languages
English (en)
Inventor
C Gessler
Thomas Nisslein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schaper und Bruemmer GmbH and Co KG
Original Assignee
Schaper und Bruemmer GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schaper und Bruemmer GmbH and Co KG filed Critical Schaper und Bruemmer GmbH and Co KG
Priority to DE50106546T priority Critical patent/DE50106546D1/de
Application granted granted Critical
Publication of DE50106546D1 publication Critical patent/DE50106546D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
DE50106546T 2000-11-03 2001-10-12 Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz Expired - Lifetime DE50106546D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50106546T DE50106546D1 (de) 2000-11-03 2001-10-12 Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054641A DE10054641A1 (de) 2000-11-03 2000-11-03 Verwendung einer Zubereitung von Cimicifuga racemosa
DE50106546T DE50106546D1 (de) 2000-11-03 2001-10-12 Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz
PCT/DE2001/003926 WO2002036140A2 (de) 2000-11-03 2001-10-12 Verwendung einer zubereitung von cimicifuga racemosa

Publications (1)

Publication Number Publication Date
DE50106546D1 true DE50106546D1 (de) 2005-07-21

Family

ID=7662102

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10054641A Withdrawn DE10054641A1 (de) 2000-11-03 2000-11-03 Verwendung einer Zubereitung von Cimicifuga racemosa
DE50106546T Expired - Lifetime DE50106546D1 (de) 2000-11-03 2001-10-12 Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10054641A Withdrawn DE10054641A1 (de) 2000-11-03 2000-11-03 Verwendung einer Zubereitung von Cimicifuga racemosa

Country Status (9)

Country Link
US (1) US6713097B2 (de)
EP (1) EP1330255B1 (de)
JP (1) JP2004512368A (de)
AT (1) ATE297747T1 (de)
AU (2) AU1814302A (de)
DE (2) DE10054641A1 (de)
ES (1) ES2240554T3 (de)
TW (1) TWI292319B (de)
WO (1) WO2002036140A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053288A1 (fr) 2000-01-20 2001-07-26 Eisai Co., Ltd. Nouveaux composes de piperidine et medicaments contenant ces composes
DE10146159A1 (de) * 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
US7060304B2 (en) * 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US6994874B2 (en) * 2003-04-16 2006-02-07 Access Business Group International, Llc Skin whitening compositions containing asparagus extract
EP2545932A1 (de) 2011-07-12 2013-01-16 Bionorica Se Ausgewählte Cimicifuga-Fraktionen zur Behandlung von Osteoporose
WO2013007807A1 (de) 2011-07-12 2013-01-17 Bionorica Se Ausgewählte cimicifuga-fraktionen zur behandlung von osteoporose
EP2620155A1 (de) 2012-01-30 2013-07-31 Bionorica SE Arzneimittel enthaltend Cimicifuga zur Anwendung bei der Behandlung von Sarkopenie und Herzmuskelschwäche
US20150313956A1 (en) * 2014-05-05 2015-11-05 Napier Consulting Llc Compositions and methods for hair growth

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
DE19812204A1 (de) 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung

Also Published As

Publication number Publication date
EP1330255B1 (de) 2005-06-15
EP1330255A2 (de) 2003-07-30
WO2002036140A3 (de) 2002-09-19
DE10054641A1 (de) 2002-05-16
US20030049340A1 (en) 2003-03-13
ES2240554T3 (es) 2005-10-16
ATE297747T1 (de) 2005-07-15
US6713097B2 (en) 2004-03-30
WO2002036140A2 (de) 2002-05-10
AU1814302A (en) 2002-05-15
JP2004512368A (ja) 2004-04-22
TWI292319B (en) 2008-01-11
AU2002218143B2 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
ATE303156T1 (de) Verwendung von gnrh-analogue zur behandlung der harninkontinenz
DE602005026638D1 (de) Gerät zur behandlung von organvorfall im weiblichen becken
EA200001044A2 (ru) Соединения для лечения женской сексуальной дисфункции
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
DE60122756D1 (de) Vorrichtung zum behandeln der weiblichen harninkontinenz
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
EP2377528A3 (de) Fettsäure-Stoffwechsel-Hemmer zur Verwendung in der Behandlung von Krebs
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE333874T1 (de) Konjugierte linolensäure zur behandlung von cyclooxygenase-2 vermittelten entzündungen und schmerzen
DE60026152D1 (de) Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs
ATE297747T1 (de) Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
TR200201250T2 (tr) Hidroksieikosatetraenoat tuzları, bileşimleri ve bunların göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri.
WO2002015844A3 (en) Antimicrobial composition and methods of use in the treatment of disease
CY1106289T1 (el) Χρηση αναστολεων υποδοχεος προγεστepονης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου που ειναι ανθεκτικος σε στepοειδη
UY26474A1 (es) Inhibidores de aminotransferasa dependiente de aminoácidos de cadena ramificada, y su uso en el tratamiento de la retinopatía diabética.
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
EA199900091A1 (ru) Терапевтическое применение t-bam(cd40l)-технологии для лечения заболеваний с участием клеток гладкой мускулатуры
DE602004003173D1 (de) Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
ES2180345T3 (es) Nuevo procedimiento para la crio-conservacion de plantas.
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
DE50202941D1 (de) Verwendung von extrakten aus cimicifuga-arten als organselektives arzneimittel zur behandlung von sexualhormonabhängigen erkrankungen des urogenitaltraktes
ATE530177T1 (de) Geruchlose formulierung zur behandlung von schleimhautdiskontinuitäten
DE60117685D1 (de) Topische zusammensetzung und methode zur behandlung von harninkontinenz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition